Monograph Title | Section | Source Publication | Page Number | Errata Post Date Sort ascending | Errata Official Date | Target Errata Print Publication | Target Online Fix Publication | Description |
---|---|---|---|---|---|---|---|---|
IBUPROFEN ORAL SUSPENSION | PERFORMANCE TESTS/Dissolution <711> | USPNF Online | Online | 27-May-2022 | 1-Jun-2022 | NA | NA | In Analysis: Change Result = (RU/RS) x CS x V x (D/WU) x (1/L) x 100 RU = peak area ratio of ibuprofen to benzophenone from the … Read More |
APREPITANT CAPSULES | PERFORMANCE TESTS/Dissolution <711> | USPNF Online | Online | 27-May-2022 | 1-Jun-2022 | NA | NA | Change Test 1 Dilute 1 mL of phosphoric acid with water to 1 L. to: Test 1 AND Change Dilute phosphoric acid: to: Dilute phosphoric acid: Dilute 1 mL of phosphoric acid with water to 1 L. |
DOXYCYCLINE HYCLATE | IMPURITIES/Organic Impurities | USPNF Online | Online | 27-May-2022 | 1-Jun-2022 | NA | NA | In Table 2, footnote b: Change (4S,4aR,5S,5aR,6R,12aS)-2-Acetyl-4-(dimethylamino)-4a,5a,6,12a-tetrahydro-3,5,10,12,12a-pentahydroxy-6-methyl-tetracene-1,11-dioxo-2-naphthacenecarboxamide. to: (4S,4aR,5S,5a… Read More |
DIMENHYDRINATE TABLETS | OTHER COMPONENTS/8-Chlorotheophylline | USPNF Online | Online | 27-May-2022 | 1-Jun-2022 | NA | NA | In Analysis: Change CU = nominal concentration of dimenhydrinate in the Sample solution (mg/mL) to: CU = determined concentration of dimenhydrinate in the Sample solution, as obtained in the Assay… Read More |
AZITHROMYCIN FOR ORAL SUSPENSION | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 27-May-2022 | 1-Jun-2022 | NA | NA | In USP Azithromycin Related Compound F RS: Change 762.97 to: 762.98 AND In USP Desosaminylazithromycin RS: Change 590.79 to: 590.80 |
ATRACURIUM BESYLATE | CHEMICAL INFORMATION | USPNF Online | Online | 27-May-2022 | 1-Jun-2022 | NA | NA | Change 2-(2-Carboxyethyl)-1,2,3,4-tetrahydro-6,7-dimeth oxy-2-methyl-1-veratrylisoquinolinium benzenesulfonate, pentamethylene ester to: 2-(2-Carboxyethyl)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-veratrylisoquinolinium benzenesulfonate,… Read More |
CARBAMAZEPINE TABLETS | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 27-May-2022 | 1-Jun-2022 | NA | NA | In USP Carbamazepine Related Compound A RS: Change 238.28 to: 238.29 AND In USP Carbamazepine Related Compound B RS: Change 193.24 to: 193.25 AND In USP 9-Methylacridine RS: Change 193.24 to: 193.25 |
<565> BOTANICAL EXTRACTS | PREPARATIONS | USPNF Online | Online | 27-May-2022 | 1-Jun-2022 | NA | NA | In General Pharmacopeial Requirements/Pesticide Residues: Change where L is the limit in the original article as listed in Table 4 (see Pesticide Residue Analysis under Articles of Botanical Origin <561>)… Read More |
DOXYCYCLINE HYCLATE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 27-May-2022 | 1-Jun-2022 | NA | NA | In USP Doxycycline Related Compound A RS: Change 444.43 to: 444.44 AND Change 480.13 to: 480.90 |
ACYCLOVIR | ASSAY/Procedure | USPNF Online | Online | 29-Apr-2022 | 1-May-2023 | NA | NA | In the Sample solution: Change 0.1 N sodium hydroxide to: 0.01 N sodium hydroxide |
DACARBAZINE FOR INJECTION | IMPURITIES | USPNF Online | Online | 29-Apr-2022 | 1-May-2022 | NA | NA | Delete Limit of 2-Azahypoxanthine test |
MUPIROCIN OINTMENT | IMPURITIES/Organic Impurities/Table 2 | USPNF Online | Online | 29-Apr-2022 | 1-May-2022 | NA | NA | In footnote b: Change 9-{(E)-4-[(2R,3aS,6S,7S,8aRS)-2-{(1RS,2S,3S)-1,3-Dihydroxy-2-methylbutyl}-7-hydroxyhexahydro-2H-furo[3,2-c]pyran-6-yl]-3-methylbut-2-enoyloxy}nonanoic acid. to:… Read More |
MECAMYLAMINE HYDROCHLORIDE | USP Reference standards <11> | USPNF Online | Online | 29-Apr-2022 | 1-May-2022 | NA | NA | In USP Mecamylamine Related Compound A RS: Change N,1,7,7-Tetramethyl bicyclo [2.2.1]heptan-2-amine. C11H21N 167.29 to: N,1,7,7-Tetramethylbicyclo[2.2.1]heptan-2-amine hydrochloride. C11… Read More |
MUPIROCIN CALCIUM | CHEMICAL INFORMATION | USPNF Online | Online | 29-Apr-2022 | 1-May-2022 | NA | NA | Change 1075.34 to: 1075.35 |
<621> CHROMATOGRAPHY | ADJUSTMENT OF CHROMATOGRAPHIC CONDITIONS | USPNF Online | Online | 29-Apr-2022 | 1-Dec-2022 | NA | NA | In Liquid Chromatography: Isocratic Elution/Injection volume: Change Result = (Vinj2 = Vinj1 (L2 dc22 )/(L1… Read More |
MUPIROCIN CREAM | Related compounds/Table 1 | USPNF Online | Online | 29-Apr-2022 | 1-May-2022 | NA | NA | In footnote 2: Change 9-{(E)-4-[(2R,3aS,6S,7S,8aRS)-2-{(1RS,2S,3S)-1,3-Dihydroxy-2-methylbutyl}-7-hydroxyhexahydro-2H-furo[3,2-c]pyran-6-yl]-3-methylbut-2-enoyloxy}nonanoic acid. to:… Read More |
BROMOCRIPTINE MESYLATE CAPSULES | PERFORMANCE TESTS/Dissolution <711> | USPNF Online | Online | 29-Apr-2022 | 1-May-2022 | NA | NA | In Analysis: Change bromocriptine mesylate (C32H40BrN5O5 · CH4SO3) to: bromocriptine (C32H40BrN5O5) AND In… Read More |
DACARBAZINE FOR INJECTION | IDENTIFICATION | USPNF Online | Online | 29-Apr-2022 | 1-May-2022 | NA | NA | Delete Identification test C |
MUPIROCIN CALCIUM | IMPURITIES/Organic Impurities/Table 1 | USPNF Online | Online | 29-Apr-2022 | 1-May-2022 | NA | NA | In footnote b: Change 9-{(E)-4-[(2R,3aS,6S,7S,8aRS)-2-{(1RS,2S,3S)-1,3-Dihydroxy-2-methylbutyl}-7-hydroxyhexahydro-2H-furo[3,2-c]pyran-6-yl]-3-methylbut-2-enoyloxy}nonanoic acid. to:… Read More |
MUPIROCIN NASAL OINTMENT | Related compounds/Table 1 | USPNF Online | Online | 29-Apr-2022 | 1-May-2022 | NA | NA | In footnote 2: Change 9-{(E)-4-[(2R,3aS,6S,7S,8aRS)-2-{(1RS,2S,3S)-1,3-Dihydroxy-2-methylbutyl}-7-hydroxyhexahydro-2H-furo[3,2-c]pyran-6-yl]-3-methylbut-2-enoyloxy}nonanoic acid. to:… Read More |
<621> CHROMATOGRAPHY | SYSTEM SUITABILITY | USPNF Online | Online | 25-Mar-2022 | 1-Dec-2022 | NA | NA | Change System Repeatability—Assay of an Active Substance or an Excipient to: System Repeatability |
MAGNESIUM OXIDE | IMPURITIES/Limit of Calcium | USPNF Online | Online | 25-Feb-2022 | 1-Dec-2022 | NA | NA | In Analysis: Change CU = concentration of Magnesium Hydroxide in the Sample solution (mg/mL) to: CU = concentration of Magnesium Oxide in the Sample solution (mg/mL) |
<659> PACKAGING AND STORAGE REQUIREMENTS | GENERAL DEFINITIONS/Packaging Definitions | Second Supplement to USP43–NF38 | Online | 26-Mar-2021 | 1-Dec-2025 | NA | NA | In Light-resistant container: Change 〈661.2〉, Functionality, Spectral Transmission Requirements for Light-Resistant Components and Systems. to: 〈661.2〉, Functionality Test Method, Spectral Transmission Requirements for Light-… Read More |